These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21440102)

  • 21. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes.
    Lajavardi L; Bochot A; Camelo S; Goldenberg B; Naud MC; Behar-Cohen F; Fattal E; de Kozak Y
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3230-8. PubMed ID: 17591893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer.
    Sanders NN; Peeters L; Lentacker I; Demeester J; De Smedt SC
    J Control Release; 2007 Oct; 122(3):226-35. PubMed ID: 17574287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of nanoparticles in ophthalmology.
    Diebold Y; Calonge M
    Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal cephalothin in experimental staphylococcal endophthalmitis.
    Rutgard JJ; Berkowitz RA; Peyman GA
    Ann Ophthalmol; 1978 Mar; 10(3):293-8. PubMed ID: 655538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
    Ophthalmic Res; 2008; 40(3-4):145-50. PubMed ID: 18421229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Think global--act local: intravitreal drug delivery systems in chronic noninfectious uveitis.
    Hazirolan D; Pleyer U
    Ophthalmic Res; 2013; 49(2):59-65. PubMed ID: 23258374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery.
    Mishra D; Gade S; Glover K; Sheshala R; Singh TRR
    Curr Eye Res; 2023 Feb; 48(2):208-218. PubMed ID: 36036478
    [No Abstract]   [Full Text] [Related]  

  • 33. Saccade movements effect on the intravitreal drug delivery in vitreous substitutes: a numerical study.
    Modareszadeh A; Abouali O; Ghaffarieh A; Ahmadi G
    Biomech Model Mechanobiol; 2013 Apr; 12(2):281-90. PubMed ID: 22581303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained transscleral drug delivery.
    Barocas VH; Balachandran RK
    Expert Opin Drug Deliv; 2008 Jan; 5(1):1-10. PubMed ID: 18095925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection.
    Li H; Palamoor M; Jablonski MM
    Nanotoxicology; 2016 Oct; 10(8):1152-9. PubMed ID: 27108911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir.
    Berthe P; Baudouin C; Garraffo R; Hofmann P; Taburet AM; Lapalus P
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1038-45. PubMed ID: 8125715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.